PT730465E - Utilizacao de angiotensina iii e de analogos desta em cicatrizacao de tecidos - Google Patents

Utilizacao de angiotensina iii e de analogos desta em cicatrizacao de tecidos

Info

Publication number: PT730465E
Authority: PT; Portugal
Prior art keywords: analogs; utilization; angiotensin iii; wound healing; scissoring
Prior art date: 1993-09-24

Application number

PT94928150T

Other languages

English (en)

Inventor

Kathleen Elizabeth Rodgers

Gere Stodder Dizerega

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-24

Filing date

1994-09-19

Publication date

2002-06-28

1994-09-19 Application filed by Univ Southern California filed Critical Univ Southern California

2002-06-28 Publication of PT730465E publication Critical patent/PT730465E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Vascular Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PT94928150T 1993-09-24 1994-09-19 Utilizacao de angiotensina iii e de analogos desta em cicatrizacao de tecidos PT730465E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US12636893A	1993-09-24	1993-09-24

Publications (1)

Publication Number	Publication Date
PT730465E true PT730465E (pt)	2002-06-28

Family

ID=22424455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT94928150T PT730465E (pt)	1993-09-24	1994-09-19	Utilizacao de angiotensina iii e de analogos desta em cicatrizacao de tecidos

Country Status (13)

Country	Link
US (1)	US5629292A (pt)
EP (1)	EP0730465B1 (pt)
JP (1)	JPH09502977A (pt)
AT (1)	ATE210677T1 (pt)
AU (1)	AU706333B2 (pt)
CA (1)	CA2172493C (pt)
DE (1)	DE69429450T2 (pt)
DK (1)	DK0730465T3 (pt)
ES (1)	ES2168312T3 (pt)
PT (1)	PT730465E (pt)
TW (1)	TW311088B (pt)
WO (1)	WO1995008337A1 (pt)
ZA (1)	ZA947338B (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5955430A (en) *	1993-09-24	1999-09-21	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
AU758319B2 (en) *	1994-11-14	2003-03-20	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
US6528483B2 (en)	1995-06-07	2003-03-04	André Beaulieu	Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en)	1995-06-07	2006-09-26	Andre Beaulieu	Solid wound healing formulations containing fibronectin
MY121607A (en) *	1995-07-10	2006-02-28	Hyundai Curitel Inc	Grid moving method of object image and apparatus using the same and compaction/motion estimation method using the same and apparatus thereof
US6110895A (en) *	1996-12-16	2000-08-29	University Of Southern California	Method of promoting healing in skin grafts
EP1410801B1 (en)	1997-01-28	2013-04-10	University Of Southern California	Method for promoting hematopoietic cell proliferation and differentiation
US6335195B1 (en)	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
WO1998033813A2 (en) *	1997-02-04	1998-08-06	University Of Southern California	Method for accelerating healing of thermal injuries
US6197751B1 (en)	1997-11-10	2001-03-06	The United States Of America As Represented By The Department Of Health And Human Services	Thymosin α1 promotes tissue repair, angiogenesis and cell migration
US6248587B1 (en)	1997-11-26	2001-06-19	University Of Southern Cailfornia	Method for promoting mesenchymal stem and lineage-specific cell proliferation
JP2002507383A (ja) *	1997-11-26	2002-03-12	ユニヴァースティオブサザーンカリフォルニア	造血および間葉細胞の増殖並びに分化を促進する方法
EP1036089B1 (en) *	1997-12-12	2004-06-09	University Of Southern California	Wound healing compositions
EP1053004A2 (en)	1998-02-09	2000-11-22	University Of Southern California	Use of angiotensin analogues for promoting erythropoiesis
US6455500B1 (en)	1998-03-10	2002-09-24	University Of Southern California	Radiation therapy methods
US7173011B2 (en)	2000-11-20	2007-02-06	University Of Southern California	Radiation therapy methods
WO1999046285A2 (en)	1998-03-11	1999-09-16	University Of Southern California	Method of promoting production of living tissue equivalents
AU752041B2 (en) *	1998-04-09	2002-09-05	University Of Southern California	Methods for treatment and prevention of infections
US6762167B1 (en)	1998-05-11	2004-07-13	University Of Southern California	Methods for treating a patient undergoing chemotherapy
EP1073453B1 (en)	1998-05-11	2005-04-13	University Of Southern California	Use of angiotensin analogs for the manufacture of a medicament for increasing white blood cell survival and mobilizing haematopoietic progenitor cells following chemotherapy
ES2207258T3 (es)	1998-07-13	2004-05-16	University Of Southern California	Procedimiento para acelerar el crecimiento oseo y del cartilago y su recuperacion.
US6916783B2 (en) *	1998-07-13	2005-07-12	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
EP1105149A1 (en) *	1998-08-13	2001-06-13	University Of Southern California	Methods to increase blood flow to ischemic tissue
DE60017211T2 (de)	1999-02-17	2005-06-02	Pfizer Products Inc., Groton	Fusionsproteine mit Trägern welche eine doppelte Immunantwort induzieren
US6730775B1 (en)	1999-03-23	2004-05-04	University Of Southern California	Methods for limiting scar and adhesion formation
US7338938B2 (en)	1999-05-10	2008-03-04	University Of Southern California	Methods for treating a patient undergoing chemotherapy
US6821953B1 (en)	1999-12-16	2004-11-23	University Of Southern California	Methods for treating and preventing damage to mucosal tissue
US6747008B1 (en)	2000-06-19	2004-06-08	University Of Southern California	Methods for treating and preventing alopecia
WO2002043731A2 (en) *	2000-11-30	2002-06-06	University Of Florida	Treatments for neurogenetic disorders, impulse control disorders, and wound healing
WO2002087504A2 (en) *	2001-05-01	2002-11-07	University Of Southern California	Methods for inhibiting tumor cell proliferation
US20100190711A1 (en) *	2007-09-11	2010-07-29	Dorian Bevec	Big gastrin i as a therapeutic agent
KR20100058558A (ko) *	2007-09-11	2010-06-03	몬도바이오테크 래보래토리즈 아게	치료제로서의 소마토스타틴―１４의 용도
CA2699077A1 (en) *	2007-09-11	2009-04-02	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
EP2197465A2 (en) *	2007-09-11	2010-06-23	Mondobiotech Laboratories AG	Use of angiotensin ii as a therapeutic agent in the treatment of eg s. pneumoniae infection
WO2009033820A2 (en) *	2007-09-11	2009-03-19	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
WO2009114461A2 (en) *	2008-03-10	2009-09-17	University Of Southern California	Angiotensin (1-7) dosage forms and uses thereof
AU2009333883B2 (en)	2008-12-29	2015-05-21	Trevena, Inc.	Beta-arrestin effectors and compositions and methods of use thereof
JP5469777B2 (ja)	2011-02-02	2014-04-16	ユニバーシティーオブサザンカリフォルニア	糖尿病性足部潰瘍を処置するための方法
BR112014018709A8 (pt)	2012-01-31	2017-07-11	Trevena Inc	Composições e efetores de beta-arrestina e métodos de uso dos mesmos
US8557958B1 (en)	2012-06-18	2013-10-15	Tarix Pharmaceuticals Ltd.	Compositions and methods for treatment of diabetes
US8633158B1 (en)	2012-10-02	2014-01-21	Tarix Pharmaceuticals Ltd.	Angiotensin in treating brain conditions
AU2014284496A1 (en)	2013-07-03	2016-01-21	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Method for treating cognitive dysfunction
WO2015120316A1 (en)	2014-02-07	2015-08-13	Trevena, Inc.	Crystalline and amorphous forms of a beta-arrestin effector
US9333233B2 (en)	2014-02-25	2016-05-10	Tarix Pharmaceuticals Ltd.	Methods and compositions for the delayed treatment of stroke
EP3145524A4 (en)	2014-05-19	2018-03-14	Trevena, Inc.	Synthesis of beta-arrestin effectors
CA2955656C (en)	2014-07-21	2023-03-14	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Ang-(1-7) derivative oligopeptides and methods for using and producing the same
US10183055B2 (en)	2014-07-21	2019-01-22	Arizona Board Of Regents On Behalf Of The University Of Arizona	Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
EP3373951B1 (en) *	2015-10-14	2021-11-17	Tarix Pharmaceuticals Ltd.	Methods and compositions for the treatment of epidermolysis bullosa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3886134A (en) *	1970-03-09	1975-05-27	Morton Norwich Products Inc	Analogues of angiotensin II
US5015629A (en) *	1989-06-26	1991-05-14	University Of Southern California	Tissue repair

1994
- 1994-09-19 PT PT94928150T patent/PT730465E/pt unknown
- 1994-09-19 DK DK94928150T patent/DK0730465T3/da active
- 1994-09-19 CA CA002172493A patent/CA2172493C/en not_active Expired - Lifetime
- 1994-09-19 WO PCT/US1994/010503 patent/WO1995008337A1/en active IP Right Grant
- 1994-09-19 EP EP94928150A patent/EP0730465B1/en not_active Expired - Lifetime
- 1994-09-19 JP JP7509853A patent/JPH09502977A/ja not_active Ceased
- 1994-09-19 DE DE69429450T patent/DE69429450T2/de not_active Expired - Fee Related
- 1994-09-19 ES ES94928150T patent/ES2168312T3/es not_active Expired - Lifetime
- 1994-09-19 AU AU77302/94A patent/AU706333B2/en not_active Ceased
- 1994-09-19 AT AT94928150T patent/ATE210677T1/de not_active IP Right Cessation
- 1994-09-21 ZA ZA947338A patent/ZA947338B/xx unknown
- 1994-11-05 TW TW083110297A patent/TW311088B/zh active
- 1994-11-14 US US08/337,781 patent/US5629292A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ZA947338B (en)	1995-05-10
JPH09502977A (ja)	1997-03-25
EP0730465A1 (en)	1996-09-11
US5629292A (en)	1997-05-13
WO1995008337A1 (en)	1995-03-30
AU7730294A (en)	1995-04-10
CA2172493C (en)	2003-09-16
DE69429450D1 (de)	2002-01-24
EP0730465A4 (en)	1997-11-12
CA2172493A1 (en)	1995-03-30
ES2168312T3 (es)	2002-06-16
EP0730465B1 (en)	2001-12-12
AU706333B2 (en)	1999-06-17
ATE210677T1 (de)	2001-12-15
DE69429450T2 (de)	2002-07-25
TW311088B (pt)	1997-07-21
DK0730465T3 (da)	2002-04-08

Publication	Publication Date	Title
PT730465E (pt)	2002-06-28	Utilizacao de angiotensina iii e de analogos desta em cicatrizacao de tecidos
MX9703609A (es)	1997-08-30	Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
DE69435301D1 (de)	2010-08-26	Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung
DE69824445D1 (de)	2004-07-15	Zusammensetzungen zur wundheilung
BRPI9908182B8 (pt)	2018-08-14	composições de proteína de matriz para cura de feridas
KR960003732A (ko)	1996-02-23	상처 치료용 멸균 겔 조성물
MX9306239A (es)	1994-06-30	Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
EE03975B1 (et)	2003-02-17	Keratinotsüüdi kasvufaktori analoogid
DE60040753D1 (de)	2008-12-18	Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
BR9507730A (pt)	1997-09-23	Uso de formulações em gel como composições de tratamento
AR018357A1 (es)	2001-11-14	Acido petroselinico en una composicion y en un metodo para reducir o eliminar la irritacion o la picazon de la piel inducida por los alfa-hidroxiacidos
CA2147123A1 (en)	1994-04-28	Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo
DE69316013D1 (de)	1998-02-05	Verwendung von phosphinate zur behandlung der osteoporose
ES2134237T3 (es)	1999-10-01	Composiciones farmaceuticas que contienen acido ursodesoxicolico.
DE69705110D1 (de)	2001-07-12	Topische pharmazeutische zusammensetzungen, welche heparin enthalten
NO985679D0 (no)	1998-12-04	Dihydrobenzopyran og beslektede forbindelser nyttige som anti-inflammasjonsmidler
EA199700241A1 (ru)	1998-02-26	Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
BR9611472A (pt)	1999-02-02	Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
UY26514A1 (es)	2001-07-31	" composición para el tratamiento de tejidos danados".
ES2121109T3 (es)	1998-11-16	Composicion de champu.
MX9709983A (es)	1998-03-29	El uso de agonistas receptores tipo 2 de angiotesina ii en la preparacion de composiciones para la preparacion de tejidos.
DE69824862D1 (de)	2004-08-05	Zusammenstellungen zur verbesserten wundheilung
ATE324898T1 (de)	2006-06-15	Behandlung von hiv infektionen
EA200100010A1 (ru)	2001-06-25	Местное применение оксазолидинонов для трансдермальной доставки
BR9608721A (pt)	1999-10-13	Composição farmacêutica, e, processo para tratar inflamação